Trends & Forecasts

An inside view of the pharmaceutical industry in China. Where has it been, where does it stand, and where is it going?

It’s been a busy time for infectious disease vaccine news in Europe.

Our animated chart illustrates Pfizer’s changing fortunes – and the significant contribution its COVID-19 efforts have made to revenues.

Ukrainian drug discovery has been disrupted by war. We spoke to leaders of its largest player about the domestic industry’s past, present, and future.

The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.

One decade behind the EU, biosimilars are arriving in the US. What can we expect? Jeff Baldetti from Cardinal Health has a few ideas.

The Medicine Maker’s round up of the top news stories in the pharma industry in March.

Thorben Seeger wants to democratize the data held by the world’s leading genomic institutions. But what exactly does he mean by “democratize”?

Nominations and voting for the Power List, Company of the Year Awards, and Innovation Awards ends on Thursday 17 March

Enveda Biosciences Founder Viswa Colluru shares the lessons he has learned whilst charting the vast terra incognita of nature’s chemical structure